An eye toward the clinic, Israel’s Compugen works to transform itself admin June 8, 2017 Blog Read more: https://www.bioworld.com/report/BWT053017Compugen.pdf You Might Also Like LDS wins medical cannabis marketing deal December 5, 2016 United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise May 2, 2018 Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing April 11, 2018
United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise May 2, 2018
